Jonathan W. Simons

(credit: Thinkstock)

FDA To Decide By April 26 On New Xgeva Application

Amgen today announced the FDA plans to decide by April 26 on its application to expand the use of its bone treatment drug Xgeva to prevent or delay the spread of advanced prostate cancer.

08/23/2011

Follow

Get every new post delivered to your Inbox.

Join 3,444 other followers